From: The identification of human pituitary adenoma-initiating cells
Sample ID | Gender | Age | Adenoma Subtype | CD15% | CD133% | Sox2% |
---|---|---|---|---|---|---|
PA1 | M | 69 | GH | 15.92 | 1.82 | 3.55 |
PA2 | M | 72 | ACTH | 10.25 | 89.75 | 12.82 |
PA3 | M | 35 | GH | 75.15 | 1.2 | 9.53 |
PA4 | F | 66 | FSH/LH | 83.46 | 16.55 | 4.54 |
PA5 | M | 76 | GH | 7.12 | 0.54 | 3.11 |
PA6 | M | 53 | FSH/PRL | 4.11 | 23.13 | 11.35 |
PA7 | F | 26 | GH/PRL | 2.59 | 47.98 | 28.36 |
PA8 | F | 52 | Null Cell | 62.71 | 1.07 | 2.24 |
PA9 | F | 76 | LH | 4.51 | 13.11 | 9.23 |
PA10 | F | 60 | Null Cell | 80.72 | 19.29 | 2.74 |
PA11 | M | 80 | Null Cell | 84.22 | 1.99 | 2.05 |
PA12 | M | 83 | Null Cell | 14.98 | 11.32 | 4.52 |
PA13 | M | 80 | Null Cell | 72.70 | 1.52 | 2.74 |
PA14 | M | 48 | GH/PRL | 7.06 | 3.92 | 6.63 |
PA15 | M | 51 | GH/PRL | 3.11 | 1.42 | 3.13 |
PA16 | M | 70 | Null Cell | 53.12 | 0.45 | 1.19 |
PA17 | M | 42 | GH | 99.56 | 0.47 | 19.24 |
PA18 | M | 64 | Null Cell | 7.23 | 12.21 | 7.31 |
PA19 | M | 52 | Null Cell | 98.86 | 0.96 | 15.07 |
PA20 | M | 72 | GH | 9.86 | 2.26 | 1.78 |
PA21 | F | 71 | Null Cell | 62.12 | 1.11 | 1.42 |
PA22 | F | 71 | Null Cell | 44.15 | 1.78 | 2.51 |